Suppr超能文献

前脑啡肽A片段在体内表现出脊髓和脊髓上的阿片样活性。

Proenkephalin A fragments exhibit spinal and supraspinal opioid activity in vivo.

作者信息

Dray A, Nunan L, Wire W

出版信息

J Pharmacol Exp Ther. 1985 Dec;235(3):670-6.

PMID:3001272
Abstract

The inhibition of reflex urinary bladder contractions, recorded isometrically in the urethane-anesthesized rat, was used as an index of central opioid activity. Inhibition of bladder activity has been shown to be mediated both spinally and supraspinally by mu and delta opioid receptors. Using this model a number of neuropeptide fragments of the proenkephalin A molecule (peptide F, peptide E, BAM 22P, BAM 12P, Met5-enkephalin-Arg6,Phe7,Leu8, Met5-enkephalin-Arg6,Phe7, Met-enkephalin, Leu-enkephalin) were tested for in vivo activity. Each of the fragments inhibited reflex bladder contractions when administered by bolus microinjection into a lateral ventricle (i.c.v.) or intrathecally into the spinal subarachnoid space (between L3 and L4 vertebra). The larger molecular weight peptides produced more prolonged inhibition of bladder activity than the smaller molecular weight ones, with the rank order of activity being similar at spinal and supraspinal sites: peptide F greater than or equal to peptide E = BAM 22P greater than BAM 12P greater than Met5-enkephalin-Arg6,Phe7,Leu8 = Met5-enkephalin-Arg6,Phe7 greater than or equal to Met-enkephalin = Leu-enkephalin. The relative receptor selectivity of each fragment was further determined using the opioid antagonists naloxone (mu receptors) and ICI 174,864 (N, N-diallyl-Tyr-Aib-Aib-Phe-Leu-OH: Aib = alpha-aminoisobutyric acid) (delta receptors). The activity (Ke) of each antagonist against equieffective doses of the highly selective opioid receptor ligands [D-Ala2,Me-Phe4,Gly(ol)5]enkephalin (mu receptors) and [D-Pen2,D-Pen5]enkephalin (delta receptors) was compared with that against the proenkephalin A fragments.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

在氨基甲酸乙酯麻醉的大鼠中,通过等长记录抑制反射性膀胱收缩,以此作为中枢阿片样物质活性的指标。膀胱活动的抑制已被证明是由μ和δ阿片受体在脊髓和脊髓以上水平介导的。利用该模型,对脑啡肽原A分子的一些神经肽片段(肽F、肽E、BAM 22P、BAM 12P、甲硫氨酸脑啡肽-精氨酸6-苯丙氨酸7-亮氨酸8、甲硫氨酸脑啡肽-精氨酸6-苯丙氨酸7、甲硫氨酸脑啡肽、亮氨酸脑啡肽)进行了体内活性测试。当通过侧脑室(脑室内)推注微量注射或鞘内注射到脊髓蛛网膜下腔(L3和L4椎骨之间)给药时,每个片段均能抑制反射性膀胱收缩。分子量较大的肽对膀胱活动的抑制作用比分子量较小的肽更持久,在脊髓和脊髓以上部位的活性排序相似:肽F≥肽E = BAM 22P>BAM 12P>甲硫氨酸脑啡肽-精氨酸6-苯丙氨酸7-亮氨酸8 = 甲硫氨酸脑啡肽-精氨酸6-苯丙氨酸7≥甲硫氨酸脑啡肽 = 亮氨酸脑啡肽。使用阿片受体拮抗剂纳洛酮(μ受体)和ICI 174,864(N,N-二烯丙基-酪氨酸-丙氨酸-丙氨酸-苯丙氨酸-亮氨酸-OH:丙氨酸 = α-氨基异丁酸)(δ受体)进一步确定每个片段的相对受体选择性。将每种拮抗剂对高选择性阿片受体配体[D-丙氨酸2,甲基苯丙氨酸4,甘氨酸(醇)5]脑啡肽(μ受体)和[D-青霉胺2,D-青霉胺5]脑啡肽(δ受体)等效剂量的活性(Ke)与对脑啡肽原A片段的活性进行比较。(摘要截短于250字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验